Wapnick Pamela
SEC CIK 1995657 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MGX | Metagenomi Therapeutics, Inc. | CFO | 206.6K | — | $41.2K | 13 | 2024-04-01 | 2026-09-08 |
Most active insiders at MGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reid Laurence | Dir | $23.4K | — |
| 2 | Irish Jian | See Remarks, Dir | — | $12.7K |
| 3 | Wapnick Pamela | CFO | — | $11.3K |
| 4 | Thomas Brian C. | Dir | — | $6,779 |
| 5 | Wein Matthew | See Remarks | — | $2,263 |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 15:34 | 2026-09-08 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $1.16 | -1,911 | 206.6K | -0.9% | -$2,214 | |
| 2026-06-10 11:23 | 2026-06-05 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $1.30 | -2,884 | 208.5K | -1% | -$3,746 | |
| D | 2026-04-03 13:40 | 2026-04-01 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | A - Grant | $0.00 | +24.0K | 211.4K | +13% | $0 |
| 2026-03-09 | 2026-03-05 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $1.60 | -1,581 | 187.4K | -0.8% | -$2,530 | |
| 2025-12-08 | 2025-12-05 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $1.77 | -1,576 | 189.0K | -0.8% | -$2,790 | |
| 2025-12-01 | 2025-09-05 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $1.81 | -1,576 | 70.5K | -2% | -$2,853 | |
| 2025-12-01 | 2025-12-01 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | A - Grant | $1.60 | +120.0K | 190.5K | +170% | +$192.0K | |
| 2025-06-09 | 2025-06-06 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $1.75 | -1,576 | 72.1K | -2% | -$2,758 | |
| D | 2025-04-03 | 2025-04-01 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | A - Grant | $0.00 | +14.0K | 73.7K | +23% | $0 |
| 2025-03-07 | 2025-03-05 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $1.87 | -1,808 | 59.7K | -3% | -$3,381 | |
| 2024-12-06 | 2024-12-05 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $1.86 | -1,559 | 61.5K | -2% | -$2,900 | |
| 2024-09-06 | 2024-09-05 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | S - Sale | $2.88 | -6,265 | 63.1K | -9% | -$18.0K | |
| D | 2024-04-03 | 2024-04-01 | MGX | Metagenomi Therapeutics, Inc. | Wapnick Pamela | CFO | A - Grant | $0.00 | +69.3K | 69.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations